etoposide has been researched along with thiosulfates in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braly, P; Howell, SB; Kim, S; Kirmani, S; McClay, EF; Plaxe, S | 1 |
| Goel, R; Horton, MC; Howell, SB; Kim, S; Kirmani, S; Lucas, WE; McVey, L; Morris, J; Weiss, RJ; Zimm, S | 1 |
| Boonstra, H; de Jong, RS; de Vries, EG; Mulder, NH; Sleijfer, DT; van der Graaf, WT; van der Zee, AG; Willemse, PH | 1 |
| Jibiki, M; Kusano, H; Matsuo, T; Miura, T; Miyashita, K; Nakagoe, T; Tomita, M | 1 |
| Malmström, H; Rasmussen, S; Simonsen, E | 1 |
| Burger, CW; Hoekman, K; van Rijswijk, RE; Verheijen, RH; Vermorken, JB | 1 |
| Brummett, RE; Doolittle, ND; Egorin, MJ; Kroll, RA; Muldoon, LL; Neuwelt, EA; Pagel, MA; Zuhowski, EG | 1 |
1 review(s) available for etoposide and thiosulfates
| Article | Year |
|---|---|
Intraperitoneal cisplatin-based chemotherapy for ovarian carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Ovarian Neoplasms; Survival Rate; Thiosulfates | 1991 |
3 trial(s) available for etoposide and thiosulfates
| Article | Year |
|---|---|
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.
Topics: Administration, Topical; Adult; Aged; Antioxidants; Cisplatin; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Cavity; Survival Rate; Thiosulfates | 1995 |
Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Injections, Intraperitoneal; Kidney; Middle Aged; Ovarian Neoplasms; Survival Rate; Thiosulfates | 1993 |
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.
Topics: Adult; Aged; Antidotes; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Infusions, Parenteral; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Survival Analysis; Thiosulfates; Treatment Outcome | 1997 |
3 other study(ies) available for etoposide and thiosulfates
| Article | Year |
|---|---|
A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Infusions, Parenteral; Ovarian Neoplasms; Remission Induction; Survival Analysis; Thiosulfates; Time Factors | 1990 |
[Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Thiosulfates | 1993 |
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
Topics: Animals; Antidotes; Auditory Threshold; Carboplatin; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Ear, Middle; Etoposide; Female; Guinea Pigs; Humans; Lung Neoplasms; Male; Rats; Rats, Long-Evans; Rats, Nude; Thiosulfates; Tumor Cells, Cultured | 2000 |